VAN SCOYOC ASSOCIATES for ZEBRA TECHNOLOGIES CORP.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Consumer Issues/Safety/Products CSP
Public Law 113-54, Drug Quality and Security Act, Drug labeling implementation Temperature monitoring technology for COVID-19 vaccines Public Law 116-260, Consolidated Appropriations Act, 2021, Division M, Coronavirus Response and Relief Supplemental Appropriations Act, 2021, Temperature monitoring technology
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES M CRUM | — |
Pharmacy PHA
Public Law 113-54, Drug Quality and Security Act, Drug labeling implementation Temperature monitoring technology for COVID-19 vaccines Public Law 116-260, Consolidated Appropriations Act, 2021, Division M, Coronavirus Response and Relief Supplemental Appropriations Act, 2021, Temperature monitoring technology
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES M CRUM | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.